(15:34 GMT) Definium Therapeutics Price Target Cut to $58.00/Share From $60.00 by Canaccord Genuity
DO Dow Jones Newswires Definium Therapeutics Is Maintained at Buy by Canaccord Genuity 6/30/2026, 11:34 PM GMT+8 Dow Jones Newswires DF DFTX (15:34 GMT) Definium Therapeutics Price Target Cut to $58.00/Share From $60.00 by Canaccord Genuity Market News Reuters LSD therapy biotech Definium fends off trade-secret lawsuit Reuters LSD therapy biotech Definium fends off trade-secret lawsuit
